Project Grant R34DA062119
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $363,310 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Vermont & State Agricultural College (UVM). The grant, titled "The Healthy Brain and Child Development Study's Scientific Training in Addiction Research Techniques Program (HBCD-START)," will provide comprehensive research education and training to prepare investigators to...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, under the Drug Use and Addiction Research Programs (CFDA 93.279), provides funding of $196,560.00 to the University of Michigan to conduct research on the neural responses to reward and threat in individuals with a history of childhood adversity. The research aims to identify predictive neurosignatures that can inform novel targeted intervention strategies for substance use...
- This Project Grant award of $840,425.00 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, under the Drug Use and Addiction Research Programs (CFDA 93.279). The funding will support research examining the impact of pre- and postnatal substance exposure, maternal distress, and related parent-child interpersonal processes on the development of adolescent risk behaviors, including substance use and delinquency. The research will leverage a...
- The National Institute on Drug Abuse (NIDA), under CFDA Program 93.279 - Drug Use and Addiction Research Programs, awarded a $1 project grant to the J. David Gladstone Institutes. The grant aims to establish a novel mouse model for studying the impact of HIV and addictive substances on the central nervous system. Specifically, the project will develop a chimeric mouse model with human microglia, neurons, and astrocytes derived from induced pluripotent stem cells. This model will be used to...
- This federal Project Grant award of $158,246.00 from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, will support research under the Drug Use and Addiction Research Programs (CFDA 93.279). The award will fund a comprehensive, longitudinal study investigating the co-occurrence of trauma, substance use, and additional stressors among Americans from childhood through adulthood. The research aims to elucidate the etiological trajectories of co-occurring...
- This federal Project Grant award of $237,000 from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), supports research on the lasting effects of early resource scarcity on astrocyte structure and function in the medial prefrontal cortex. The research project, titled "Lasting Effects of Early Resource Scarcity on Cortical Astrocyte Structure and Function", aims to determine how astrocyte morphology and function are affected by a postnatal...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $558,668 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Massachusetts Institute of Technology (MIT) for the project "Integration and Validation of Single-Cell Neuronal and Immune Molecular Responses in SUD and HIV". The project aims to uncover the genetic and molecular mechanisms driving the interactions between HIV, neuropsychiatric, and...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $608,652 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Scripps Research Institute. The purpose of this 5-year award, with a start date of September 1, 2025, is to conduct data mining and functional validation of the Systematic Characterization of Retroviral Conditions for Health (SCORCH) datasets. The research aims to elucidate the key pathogenic...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $147,486 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Trustees of the University of Pennsylvania. This 2.5-year grant, active from July 2025 to January 2028, will support research to determine how individual differences in stress susceptibility influence subsequent opioid use and the role of mu-opioid receptor-expressing neurons in the paraventricular...
- This federal Project Grant award of $811,112 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research on the network and circuit dynamics underlying dopaminergic control of sudden insight learning. The principal investigator and research team at the University of California, San Francisco (UCSF) will use a combination of large-scale two-photon calcium imaging, high-density electrophysiology, dopamine sensor fiber...
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $707,108 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Regents of the University of California, Berkeley (UC Berkeley) for the "International Development Project (IDP): An International Collaboration for the Standardized Study of Experience-Dependent Brain and Behavioral Development". The project aims to study the effects of various forms of childhood adversity, including poverty, trauma, and other stressors, on brain development and behavior. The researchers will leverage controlled experiments using mice to compare the impacts of different types of adverse experiences and develop a more comprehensive understanding of how these factors influence mental and physical health outcomes later in life. The project period runs from Sep 1, 2025 to Aug 31, 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $707.1k | 8/22/25 |